Bufferin and cardiac failure congestive Patient Reports February 10, 2010
Bufferin Side Effects Report #5254214-1
Bufferin side effect was reported by a Consumer or non-health professional from JAPAN on Feb 21, 2007. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with Bufferin. After drug was administered, patient experienced the following side effects: brain natriuretic peptide increased, cardiac failure congestive, dilatation ventricular, dyspnoea, ejection fraction decreased, pulmonary congestion. Bufferin dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL, VALSARTAN. Patient was hospitalized. Patient recovered.
Bufferin Side Effects Report #5264699-2
Bufferin side effect was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with Bufferin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, brain natriuretic peptide increased, cardiac failure congestive, cardiac murmur, dilatation ventricular. Bufferin dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL. Patient was hospitalized. Patient recovered.
Bufferin Side Effects Report #4614828-6
Bufferin side effect was reported by a Consumer or non-health professional from on Dec 22, 2004. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with Bufferin. After drug was administered, patient experienced the following side effects: bleeding time prolonged, brain natriuretic peptide increased, cardiac failure congestive, dilatation ventricular, dyspnoea, ejection fraction decreased, pulmonary congestion. Bufferin dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL, VALSARTAN. Patient was hospitalized. Patient recovered.
Bufferin Side Effects Report #4621883-6
Bufferin side effect was reported by a Consumer or non-health professional from on Dec 22, 2004. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with Bufferin. After drug was administered, patient experienced the following side effects: brain natriuretic peptide increased, cardiac failure congestive, dilatation ventricular, dyspnoea, ejection fraction decreased, pulmonary congestion. Bufferin dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL, VALSARTAN. Patient was hospitalized. Patient recovered.
Bufferin and cardiac failure congestive 